RecruitingNot ApplicableNCT06729944

Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

50 participants

Start Date

Apr 27, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to identify a dysplasia- and CCA-specific NGS panel to increase the diagnostic sensitivity of histological and/or cytological examination of biliary tract stenosis.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Availability of enough tissue for histological and NGS analysis (at least 20 ng DNA).
  • Age greater than/equal to 18 years.

Exclusion Criteria1

  • None

Interventions

DIAGNOSTIC_TESTNGS

Tissue samples will be processed and analysed at the U.O. of Pathological Anatomy


Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06729944


Related Trials